• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Research Solutions Reports Second Quarter Fiscal Year 2026 Results

    2/12/26 4:05:00 PM ET
    $RSSS
    EDP Services
    Technology
    Get the next $RSSS alert in real time by email

    Reports 14% Increase in ARR to $21.8 Million, Net Income of $547,000 and 36% Year-over-Year Growth in Adjusted EBITDA

    HENDERSON, Nev., Feb. 12, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal second quarter ended December 31, 2025.

    Research Solutions logo (PRNewsfoto/Research Solutions, Inc.)

    Fiscal Second Quarter 2026 Summary (compared to prior-year quarter)

    • Annual Recurring Revenue ("ARR") up 14% to $21.8 million, which includes approximately $15.3 million of B2B ARR and $6.4 million of B2C ARR.
    • Forty-seven net new deployments in the quarter reflect one of our best results and sustained momentum in new B2B customer acquisition.
    • Net income of $547,000, or $0.02 per diluted share, compared to net loss of $2.0 million or ($0.07) per share.
    • Adjusted EBITDA increased 36% to $1.3 million. On a trailing twelve-month ("TTM") basis, the Company has now generated Adjusted EBITDA of $5.8 million or 11.8% of revenue for the same period.
    • Net B2B ARR growth of $560,000 represents the best organic second quarter performance in Company history.
    • Gross profit up 6% to $6.2 million. Total gross margin improved 350 basis points to 52.4%.
    • Platform revenue up 14% to $5.2 million. Platform revenue accounted for 44% of total revenue as compared to 39% in the prior-year quarter.
    • Total revenue was $11.8 million compared to $11.9 million in the prior year, as strong B2B revenue growth has not yet fully offset softness in transactions revenue.

    "Our second quarter results reflect strong growth within our B2B Platforms business through forty-seven net new deployments in the quarter and Platforms continues to represent a larger portion of our total revenue mix. In addition, the average sales price for our Platform increased more than six percent year-over-year as we signed larger deals and as existing customers adopt more of our SaaS and AI solutions," said Roy W. Olivier, President and CEO of Research Solutions. "Our business continues to generate strong operating cash flow and Adjusted EBITDA, allowing us to reinvest in sales and marketing to accelerate growth while maintaining financial flexibility. We continue to manage the business with a long-term focus to drive value for our shareholders."

    Fiscal Second Quarter 2026 Results

    Total revenue was $11.8 million, compared to $11.9 million in the year-ago quarter. Platform revenue growth was offset by a decline in transactions revenue.

    Platform subscription revenue for the quarter was $5.2 million, a 14% year-over-year increase from the prior-year period. The increase was primarily due to organic growth in the core B2B platform, due to a mix of new logo generation as well as upsells and cross-selling into existing customers. The quarter ended with annual recurring revenue of $21.8 million, up 14% year-over-year (see the Company's definition of annual recurring revenue below).

    Transaction revenue was $6.6 million, compared to $7.3 million in the second quarter of fiscal 2025. The decrease was due to the impact of a known customer that churned earlier and a few larger customers that saw significant declines in volume. The transaction active customer count for the quarter was 1,321, compared to 1,384 customers in the prior-year quarter (see the Company's definition of active customer accounts and transactions below).

    Total gross margin improved 350 basis points from the prior-year quarter to 52.4%. The increase was primarily driven by the continued revenue mix shift to the higher-margin Platforms business, including the expansion of the gross margin for that business.

    Total operating expenses were $5.4 million, compared to $5.7 million in the second quarter of fiscal 2025. The decrease was primarily related to reduced general and administrative and stock-based compensation expenses offset in part by increased sales and marketing expenses. 

    Net income in the fiscal second quarter was $547,000, or $0.02 per diluted share, compared to a net loss of $2 million, or ($0.07) per share, in the prior-year quarter. Adjusted EBITDA was $1.3 million, compared to $963,000 in the year-ago quarter (see definition and further discussion about the presentation of Adjusted EBITDA, a non-GAAP term, below).

    Conference Call

    Management will host the conference call, followed by a question-and-answer period.

    Date: Thursday, February 12, 2026

    Time: 5:00 p.m. ET (2:00 p.m. PT)

    Dial-in number: 1-203-518-9708

    Conference ID: RESEARCH

    The conference call will be broadcast live and available for replay until March 12, 2026 by dialing 1-412-317-6671 and using the replay ID 11160799, and via the investor relations section of the Company's website at http://researchsolutions.investorroom.com/.

    Fiscal Second Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter































    Quarter Ended December 31,



    Six Months Ended December 31,







    2025

    2024

    Change

    % Change



    2025

    2024

    Change

    % Change



    Revenue:























    Platforms

    $     5,224,845

    $     4,601,257

    $      623,588

    13.6 %



    $   10,345,685

    $     8,930,902

    $     1,414,783

    15.8 %





    Transactions

    6,567,806

    7,312,962

    (745,156)

    -10.2 %



    13,759,151

    15,027,799

    (1,268,648)

    -8.4 %



    Total Revenue

    11,792,651

    11,914,219

    (121,568)

    -1.0 %



    24,104,836

    23,958,701

    146,135

    0.6 %

























    Gross Profit:























    Platforms

    4,602,184

    3,981,415

    620,769

    15.6 %



    9,112,649

    7,763,893

    1,348,756

    17.4 %





    Transactions

    1,574,766

    1,839,678

    (264,912)

    -14.4 %



    3,289,599

    3,823,076

    (533,477)

    -14.0 %



    Total Gross Profit

    6,176,950

    5,821,093

    355,857

    6.1 %



    12,402,248

    11,586,969

    815,279

    7.0 %

























    Gross profit as a % of revenue:























    Platforms

    88.1 %

    86.5 %

    1.6 %





    88.1 %

    86.9 %

    1.1 %







    Transactions

    24.0 %

    25.2 %

    -1.2 %





    23.9 %

    25.4 %

    -1.5 %





    Total Gross Profit

    52.4 %

    48.9 %

    3.5 %





    51.5 %

    48.4 %

    3.1 %



























    Operating Expenses:























    Sales and marketing

    1,648,597

    1,343,087

    305,510

    22.7 %



    3,315,422

    2,533,494

    781,928

    30.9 %





    Technology and product development

    1,602,421

    1,506,849

    95,572

    6.3 %



    3,012,572

    2,879,607

    132,965

    4.6 %





    General and administrative

    1,620,595

    2,008,201

    (387,606)

    -19.3 %



    3,295,954

    3,938,377

    (642,423)

    -16.3 %





    Depreciation and amortization

    316,425

    306,233

    10,192

    3.3 %



    632,491

    618,328

    14,163

    2.3 %





    Stock-based compensation

    213,449

    534,322

    (320,873)

    -60.1 %



    425,931

    952,311

    (526,380)

    -55.3 %





    Foreign currency translation loss (gain)

    36,112

    29,554

    6,558

    22.2 %



    18,856

    (74,686)

    93,542

    -125.2 %



    Total Operating Expenses

    5,437,599

    5,728,246

    (290,647)

    -5.1 %



    10,701,226

    10,847,431

    (146,205)

    -1.3 %



    Income from operations

    739,351

    92,847

    646,504

    696.3 %



    1,701,022

    739,538

    961,484

    -130.0 %

























    Other expense:























    Other expense

    (183,572)

    (2,057,887)

    1,874,315

    -91.1 %



    (374,625)

    (1,989,362)

    1,614,737

    -81.2 %





    Provision for income taxes

    (8,859)

    (15,194)

    6,335

    -41.7 %



    (30,090)

    (61,406)

    31,316

    -51.0 %



    Total Other Expense:

    (192,431)

    (2,073,081)

    1,880,650

    -90.7 %



    (404,715)

    (2,050,768)

    1,646,053

    -80.3 %



    Net income (loss)

    $        546,920

    $    (1,980,234)

    2,527,154

    -127.6 %



    $     1,296,307

    $    (1,311,230)

    2,607,537

    -198.9 %



    Adjusted EBITDA

    $     1,305,337

    $        962,956

    $      342,381

    35.6 %



    $     2,778,300

    $     2,235,491

    $        542,809

    24.3 %































    Quarter Ended December 31,



    Six Months Ended December 31,







    2025

    2024

    Change

    % Change



    2025

    2024

    Change

    % Change



    Platforms:























    B2B ARR (Annual recurring revenue*):























      Beginning of Period

    $   14,758,472

    $   12,187,834

    $   2,570,637

    21.1 %



    $   14,197,598

    $   12,060,201

    $     2,137,397

    17.7 %





       Incremental ARR

    560,482

    550,422

    10,060

    1.8 %



    1,121,356

    678,055

    443,301

    65.4 %





      End of Period

    $   15,318,954

    $   12,738,256

    $   2,580,697

    20.3 %



    $   15,318,954

    $   12,738,256

    $     2,580,698

    20.3 %



























    Deployments:























      Beginning of Period

    1,185

    1,029

    156

    15.2 %



    1,171

    1,021

    150

    14.7 %





       Incremental Deployments

    47

    61

    (14)

    -23.0 %



    61

    69

    (8)

    -11.6 %





      End of Period

    1,232

    1,090

    142

    13.0 %



    1,232

    1,090

    142

    13.0 %



























    ASP (Average sales price):























      Beginning of Period

    $          12,454

    $          11,844

    $             610

    5.2 %



    $          12,124

    $          11,812

    $               312

    2.6 %





      End of Period

    $          12,434

    $          11,686

    $             748

    6.4 %



    $          12,434

    $          11,686

    $               748

    6.4 %





























    B2C ARR (Annual recurring revenue*):























      Beginning of Period

    $     6,535,197

    $     5,430,795

    $   1,104,402

    20.3 %



    $     6,721,356

    $     5,363,129

    $     1,358,227

    25.3 %





       Incremental ARR

    (93,781)

    940,586

    (1,034,367)

    -110.0 %



    (279,940)

    1,008,252

    (1,288,192)

    -127.8 %





      End of Period

    $     6,441,416

    $     6,371,381

    $        70,035

    1.1 %



    $     6,441,416

    $     6,371,381

    $          70,035

    1.1 %





























    Total ARR (Annualized recurring revenue):

    $   21,760,370

    $   19,109,637

    $   2,650,732

    13.9 %



    $   21,760,370

    $   19,109,637

    $     2,650,733

    13.9 %



























    Transaction Customers:























    Corporate customers

    1,326

    1,051

    275

    26.2 %



    1,200

    1,063

    137

    12.9 %





    Academic customers

    324

    333

    (9)

    -2.7 %



    320

    325

    (5)

    -1.5 %





    Total customers

    1,650

    1,384

    266

    19.2 %



    1,520

    1,388

    132

    9.5 %

























    *

    Annual Recurring Revenue (Non-GAAP Measure) - the value of contracted platform subscription recurring revenue normalized to a one year period. 





    For B2C, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by 12.





    Active Customer Accounts, Transactions and Annual Recurring Revenue

    The Company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.

    A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.

    The Company defines annual recurring revenue ("ARR") as the value of contracted Platform subscription recurring revenue normalized to a one-year period. For B2C ARR, this includes the annualized value of monthly subscriptions, meaning their monthly value multiplied by twelve.

    Use of Non-GAAP Measure – Adjusted EBITDA

    Research Solutions' management evaluates and makes operating decisions using various financial metrics. In addition to the Company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the Company's operating results.

    The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other expense, foreign currency transaction (gain) loss, provision for income taxes, depreciation and amortization, stock-based compensation, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):







    Quarter Ended December 31,



    Six Months Ended December 31,







    2025

    2024

    Change

    % Change



    2025

    2024

    Change

    % Change



    Net Income (loss)

    $        546,920

    $    (1,980,234)

    $   2,527,154

    -127.6 %



    $     1,296,307

    $    (1,311,230)

    $     2,607,537

    -198.9 %



     Add (deduct):















    -







    Other expense

    183,572

    2,057,887

    (1,874,315)

    -91.1 %



    374,625

    1,989,362

    (1,614,737)

    -81.2 %





    Foreign currency translation loss (gain)

    36,112

    29,554

    6,558

    22.2 %



    18,856

    (74,686)

    93,542

    -125.2 %





    Provision for income taxes

    8,859

    15,194

    (6,335)

    -41.7 %



    30,090

    61,406

    (31,316)

    -51.0 %





    Depreciation and amortization

    316,425

    306,233

    10,192

    3.3 %



    632,491

    618,328

    14,163

    2.3 %





    Stock-based compensation

    213,449

    534,322

    (320,873)

    -60.1 %



    425,931

    952,311

    (526,380)

    -55.3 %



     Adjusted EBITDA

    $     1,305,337

    $        962,956

    $      342,381

    35.6 %



    $     2,778,300

    $     2,235,491

    $        542,809

    -24.3 %

























    About Research Solutions

    Research Solutions, Inc. (NASDAQ:RSSS) is a vertical SaaS and AI Company that simplifies research workflow for academic institutions, life science companies, and research organizations worldwide. As one of the only publisher-independent marketplaces for scientific, technical, and medical (STM) content, the Company uniquely combines AI-powered tools—including an intelligent research assistant and full-text search capabilities—with seamless access to both open access and paywalled research. The platform enables organizations to discover, access, manage and analyze scientific literature more efficiently, accelerating the pace of scientific discovery. For more information and details, please visit www.researchsolutions.com 

    Important Cautions Regarding Forward-Looking Statements

    Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding enhanced product offerings, additional customers, creating long-term value for shareholders and the Company's prospects for growth. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to officially release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission. 

    Research Solutions, Inc. and Subsidiaries

    Condensed Consolidated Balance Sheets (Unaudited)

     





    December 31, 



    June 30, 







    2025



    2025



    Assets















    Current assets:















    Cash and cash equivalents



    $

    12,262,780



    $

    12,227,312



    Accounts receivable, net of allowance of $79,869 and $182,324, respectively





    5,661,171





    7,191,234



    Prepaid expenses and other current assets





    708,075





    580,257



    Prepaid royalties





    42,155





    925



    Total current assets





    18,674,181





    19,999,728



















    Non-current assets:















    Property and equipment, net of accumulated depreciation of $992,832 and $964,883, respectively





    65,236





    60,769



    Intangible assets, net of accumulated amortization of $3,347,683 and $2,736,773, respectively





    9,130,484





    9,686,241



    Goodwill





    16,372,979





    16,372,979



    Deposits and other assets





    1,000





    957



    Total assets



    $

    44,243,880



    $

    46,120,674



















    Liabilities and Stockholders' Equity















    Current liabilities:















    Accounts payable and accrued expenses



    $

    6,397,476



    $

    7,443,757



    Deferred revenue





    9,916,853





    10,702,120



    Contingent earnout liability, current portion





    7,295,596





    7,363,152



    Total current liabilities





    23,609,925





    25,509,029



















    Non-current liabilities:















    Contingent earnout liability, long-term portion





    3,405,356





    6,683,488



    Total liabilities





    27,015,281





    32,192,517



















    Commitments and contingencies































    Stockholders' equity:















    Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding





    —





    —



    Common stock; $0.001 par value; 100,000,000 shares authorized; 32,875,476 and 32,479,993 shares issued and outstanding, respectively





    32,875





    32,480



    Additional paid-in capital





    41,056,472





    39,059,557



    Accumulated deficit





    (23,747,387)





    (25,043,693)



    Accumulated other comprehensive loss





    (113,361)





    (120,187)



    Total stockholders' equity





    17,228,599





    13,928,157



    Total liabilities and stockholders' equity



    $

    44,243,880



    $

    46,120,674



     

    Research Solutions, Inc. and Subsidiaries

    Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss)

    (Unaudited)

































    Three Months Ended



    Six Months Ended







    December 31, 



    December 31, 







    2025



    2024



    2025



    2024































    Revenue:



























    Platforms



    $

    5,224,845



    $

    4,601,257



    $

    10,345,685



    $

    8,930,902



    Transactions





    6,567,806





    7,312,962





    13,759,151





    15,027,799



    Total revenue





    11,792,651





    11,914,219





    24,104,836





    23,958,701































    Cost of revenue:



























    Platforms





    622,661





    619,842





    1,233,036





    1,167,009



    Transactions





    4,993,040





    5,473,284





    10,469,552





    11,204,723



    Total cost of revenue





    5,615,701





    6,093,126





    11,702,588





    12,371,732



    Gross profit





    6,176,950





    5,821,093





    12,402,248





    11,586,969































    Operating expenses:



























    Selling, general and administrative





    5,121,175





    5,422,013





    10,068,736





    10,229,103



    Depreciation and amortization





    316,425





    306,233





    632,491





    618,328



    Total operating expenses





    5,437,600





    5,728,246





    10,701,227





    10,847,431































    Income from operations





    739,350





    92,847





    1,701,021





    739,538































    Other income





    95,065





    348,999





    221,978





    417,524



    Change in fair value of contingent earnout liability





    (278,637)





    (2,406,886)





    (596,603)





    (2,406,886)































    Income (loss) before provision for income taxes





    555,778





    (1,965,040)





    1,326,396





    (1,249,824)



    Provision for income taxes





    (8,859)





    (15,194)





    (30,090)





    (61,406)































    Net income (loss)





    546,919





    (1,980,234)





    1,296,306





    (1,311,230)































    Other comprehensive income (loss):



























    Foreign currency translation





    5,859





    2,637





    6,826





    (3,531)



    Comprehensive income (loss)



    $

    552,778



    $

    (1,977,597)



    $

    1,303,132



    $

    (1,314,761)































    Basic income (loss) per common share:



























    Net income (loss) per share



    $

    0.02



    $

    (0.07)



    $

    0.04



    $

    (0.04)



    Weighted average common shares outstanding





    31,634,575





    30,421,808





    31,434,725





    30,384,339































    Diluted income (loss) per common share:



























    Net income (loss) per share



    $

    0.02



    $

    (0.07)



    $

    0.04



    $

    (0.04)



    Weighted average common shares outstanding





    32,333,657





    30,421,808





    32,113,408





    30,384,339



     

    Research Solutions, Inc. and Subsidiaries

    Condensed Consolidated Statements of Cash Flows

    (Unaudited)





















    Six Months Ended







    December 31, 







    2025



    2024



















    Cash flow from operating activities:















    Net income (loss)



    $

    1,296,306



    $

    (1,311,230)



    Adjustment to reconcile net income (loss) to net cash provided by operating activities:















    Depreciation and amortization





    632,491





    618,328



    Stock options expense





    149,262





    88,045



    Restricted common stock expense





    276,669





    864,266



    Adjustment to contingent earnout liability





    596,603





    2,406,886



    Changes in operating assets and liabilities:















    Accounts receivable





    1,530,063





    (266,255)



    Prepaid expenses and other current assets





    (127,818)





    (98,613)



    Prepaid royalties





    (41,230)





    478,169



    Accounts payable and accrued expenses





    (1,035,903)





    (737,670)



    Deferred revenue





    (785,267)





    (170,433)



    Net cash provided by operating activities





    2,491,176





    1,871,493



















    Cash flow from investing activities:















    Purchase of property and equipment





    (24,561)





    (5,404)



    Net cash used in investing activities





    (24,561)





    (5,404)



















    Cash flow from financing activities:















    Proceeds from the exercise of stock options





    157,500





    —



    Common stock repurchases





    (39,549)





    (205,278)



    Payment of contingent acquisition consideration - Scite and FIZ





    (2,554,394)





    (62,560)



    Net cash used in financing activities





    (2,436,443)





    (267,838)



















    Effect of exchange rate changes





    5,296





    2,873



    Net increase in cash and cash equivalents





    35,468





    1,601,124



    Cash and cash equivalents, beginning of period





    12,227,312





    6,100,031



    Cash and cash equivalents, end of period



    $

    12,262,780



    $

    7,701,155



















    Supplemental disclosures of cash flow information:















    Cash paid for income taxes



    $

    30,090



    $

    61,406



















    Non-cash investing and financing activities:















    Contingent consideration accrual on asset acquisition



    $

    20,981



    $

    30,198



    Common stock issued for Scite earnout payment



    $

    1,453,428



    $

    —



     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/research-solutions-reports-second-quarter-fiscal-year-2026-results-302686897.html

    SOURCE Research Solutions, Inc.

    Get the next $RSSS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RSSS

    DatePrice TargetRatingAnalyst
    6/30/2021$4.34Buy
    Roth Capital
    More analyst ratings

    $RSSS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO & Secretary Kutil David was granted 30,000 shares and covered exercise/tax liability with 758 shares (SEC Form 4)

    4 - Research Solutions, Inc. (0001386301) (Issuer)

    12/22/25 9:14:39 PM ET
    $RSSS
    EDP Services
    Technology

    SEC Form 3 filed by new insider Kutil David

    3 - Research Solutions, Inc. (0001386301) (Issuer)

    12/22/25 9:12:51 PM ET
    $RSSS
    EDP Services
    Technology

    SEC Form 4 filed by Director Gayron Kenneth L

    4 - Research Solutions, Inc. (0001386301) (Issuer)

    12/16/25 6:01:31 PM ET
    $RSSS
    EDP Services
    Technology

    $RSSS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Research Solutions Reports Second Quarter Fiscal Year 2026 Results

    Reports 14% Increase in ARR to $21.8 Million, Net Income of $547,000 and 36% Year-over-Year Growth in Adjusted EBITDA HENDERSON, Nev., Feb. 12, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal second quarter ended December 31, 2025. Fiscal Second Quarter 2026 Summary (compared to prior-year quarter) Annual Recurring Revenue ("ARR") up 14% to $21.8 million, which includes approximately $15.3 million of B2B ARR and $6.4 million of B2C ARR.Forty-seven net new deployments in th

    2/12/26 4:05:00 PM ET
    $RSSS
    EDP Services
    Technology

    Research Solutions to Announce Second Quarter Fiscal Year 2026 Results on Thursday, February 12, 2026

    HENDERSON, Nev., Jan. 29, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, will hold a conference call to discuss its financial results for the second quarter fiscal 2026 ended December 31, 2025, on Thursday, February 12, 2026, at 5:00 p.m. ET. A press release containing the Company's financial results will be issued following the market close. Management will host the conference call, followed by a question-and-answer period. Date: Thursday, February 12, 2026Time: 5:00 p.m. ET (2:00 p.m. PT)Dial-in number: 1-203-5

    1/29/26 2:50:00 PM ET
    $RSSS
    EDP Services
    Technology

    Research Solutions Announces CFO Transition

    HENDERSON, Nev., Dec. 11, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, announced that its Chief Financial Officer and Secretary, Bill Nurthen,  left the Company effective December 10, 2025 to pursue another opportunity. The Company has named its Controller, Dave Kutil, as interim Chief Financial Officer and Secretary. Mr. Kutil has served as Controller since joining the Company in 2023 and has more than 15 years of financial leadership experience. Prior to joining Research Solutions, he served as Controller for

    12/11/25 8:30:00 AM ET
    $RSSS
    EDP Services
    Technology

    $RSSS
    SEC Filings

    View All

    Research Solutions Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Research Solutions, Inc. (0001386301) (Filer)

    2/12/26 5:17:23 PM ET
    $RSSS
    EDP Services
    Technology

    Research Solutions Inc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Research Solutions, Inc. (0001386301) (Filer)

    12/11/25 8:35:59 AM ET
    $RSSS
    EDP Services
    Technology

    SEC Form 10-Q filed by Research Solutions Inc

    10-Q - Research Solutions, Inc. (0001386301) (Filer)

    11/14/25 4:01:14 PM ET
    $RSSS
    EDP Services
    Technology

    $RSSS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on Research Solutions with a new price target

    Roth Capital initiated coverage of Research Solutions with a rating of Buy and set a new price target of $4.35

    6/30/21 8:31:03 AM ET
    $RSSS
    EDP Services
    Technology

    Maxim Group initiated coverage on Research Solutions with a new price target

    Maxim Group initiated coverage of Research Solutions with a rating of Buy and set a new price target of $6.00

    6/18/21 8:32:12 AM ET
    $RSSS
    EDP Services
    Technology

    $RSSS
    Leadership Updates

    Live Leadership Updates

    View All

    Research Solutions Appoints Sefton Cohen as Chief Revenue Officer

    SaaS Executive with Track Record of Accelerating Growth HENDERSON, Nev., Nov. 19, 2024 /PRNewswire/ -- Research Solutions (NASDAQ:RSSS), a pioneer in scientific content delivery, today announced the appointment of Sefton Cohen as Chief Revenue Officer. Cohen brings over two decades of experience scaling high-growth SaaS companies and will play a pivotal role in accelerating Research Solutions' transformation from a scientific content provider to a comprehensive AI-enabled research intelligence platform. "Sefton's proven track record of driving triple-digit growth in the SaaS i

    11/19/24 8:00:00 AM ET
    $RSSS
    EDP Services
    Technology

    Research Solutions Announces Acquisition of scite

    Transforms Search and Discovery Solutions for Researchers by Delivering Breakthrough AI Technology Adds $3.6 Million in Annualized Software Subscription Revenue HENDERSON, Nev., Nov. 27, 2023 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, today announced their acquisition of scite, an award-winning search and discovery platform that leverages AI to increase the discoverability and evaluation of research.   RSSS) acquires scite, an award-winning search and discovery platform." alt="Research Solutions, Inc.

    11/27/23 8:00:00 AM ET
    $RSSS
    EDP Services
    Technology

    $RSSS
    Financials

    Live finance-specific insights

    View All

    Research Solutions Reports Second Quarter Fiscal Year 2026 Results

    Reports 14% Increase in ARR to $21.8 Million, Net Income of $547,000 and 36% Year-over-Year Growth in Adjusted EBITDA HENDERSON, Nev., Feb. 12, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal second quarter ended December 31, 2025. Fiscal Second Quarter 2026 Summary (compared to prior-year quarter) Annual Recurring Revenue ("ARR") up 14% to $21.8 million, which includes approximately $15.3 million of B2B ARR and $6.4 million of B2C ARR.Forty-seven net new deployments in th

    2/12/26 4:05:00 PM ET
    $RSSS
    EDP Services
    Technology

    Research Solutions to Announce Second Quarter Fiscal Year 2026 Results on Thursday, February 12, 2026

    HENDERSON, Nev., Jan. 29, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, will hold a conference call to discuss its financial results for the second quarter fiscal 2026 ended December 31, 2025, on Thursday, February 12, 2026, at 5:00 p.m. ET. A press release containing the Company's financial results will be issued following the market close. Management will host the conference call, followed by a question-and-answer period. Date: Thursday, February 12, 2026Time: 5:00 p.m. ET (2:00 p.m. PT)Dial-in number: 1-203-5

    1/29/26 2:50:00 PM ET
    $RSSS
    EDP Services
    Technology

    Research Solutions Reports First Quarter Fiscal Year 2026 Results

    Reports 21% Increase in ARR to $21.3 Million, Strong Growth in Net Income, Adjusted EBITDA and Operating Cash Flow HENDERSON, Nev., Nov. 13, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ:RSSS), the leading AI-powered research workflow platform, reported financial results for its fiscal first quarter ended September 30, 2025. Fiscal First Quarter 2026 Summary (compared to prior-year quarter) Annual Recurring Revenue ("ARR") up 21% to $21.3 million, which includes approximately $14.8 million of B2B recurring revenue and $6.5 million of B2C recurring revenue.  Net B2B ARR

    11/13/25 4:05:00 PM ET
    $RSSS
    EDP Services
    Technology

    $RSSS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Research Solutions Inc

    SC 13D/A - Research Solutions, Inc. (0001386301) (Subject)

    12/9/24 5:34:36 PM ET
    $RSSS
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Research Solutions Inc

    SC 13D/A - Research Solutions, Inc. (0001386301) (Subject)

    12/5/24 3:54:23 PM ET
    $RSSS
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Research Solutions Inc

    SC 13D/A - Research Solutions, Inc. (0001386301) (Subject)

    11/19/24 4:40:24 PM ET
    $RSSS
    EDP Services
    Technology